It all starts with a patient
Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.
How we’re making a difference.
Dr. Katelin H.
“There is nothing more powerful than sharing your story with others, whether with your own family or with the whole country. You’d be surprised how much impact simple actions can have.”
Improving the lives of individuals & families.
Global Liver Institute (GLI) is a nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness.
GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease.
GLI LIVE started in March 2020, as a COVID-19 response program for liver patients. It has now evolved into a weekly educational show with tailored information for patients living with liver diseases on a variety of timely topics.
GLI and NutriStyle Inc. have partnered to create a personalized nutrition app for people living with liver disease, diabetes, and other chronic conditions or who want to maintain good liver health. The app will create personalized meal plans to meet the specific requirements set out by GLI nutritional advisors for people with NASH or a general interest in liver health.
Global Liver Institute created Liver Central to equip everyone affected by liver cancer. We know that learning, advocacy, and collaboration empowers us to create change in the exam room, in the community, and beyond. Whether you have just received a liver cancer diagnosis, you are interested in new treatment options or clinical trials, or you’re a clinician looking for current practice guidelines, Liver Central exists to help you find the answers you pursue.
200 multidisciplinary stakeholders work together on our councils
Growth in Patient and Medical Community Engagement in NASH Community Persists Despite Recent Regulatory Disappointment
Today is International NASH Day, a time where healthcare experts and community members around the globe step up and raise awareness of the most common liver disease in the world – nonalcoholic fatty liver disease (NAFLD) – and it’s more severe form, nonalcoholic steatohepatitis (NASH).
Efforts for Improved Treatment and Diagnosis of Rare Liver Diseases
In this month’s edition, we feature the latest initiatives that GLI has taken part in to advocate for policy changes and highlight new innovations in the rare liver disease field to allow for better research opportunities and improved patient outcomes.
New Leadership & New Understanding in the Cancer World
Globally, liver cancer is the third leading cause of cancer death. It’s not only important to GLI to keep you updated; we value your input and updates.